Solventum Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Solventum's inventory turnover ratio, the ratio that measures Solventum's ability to manage its supply chain, sequentially decreased to 3.22 in the second quarter 2026, which does not come as a surprise, as the Solventum continue to experience headwinds, which also impact its supply chain. Average processing period, for Solventum's inventories remained unchanged at 113 days, in the Jun 30 2026 quarter.

Within Healthcare sector 119 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the first quarter 2026, to 1150.

SOLV Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Solventum Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SOLV Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	8.11 %	25.75 %	24.39 %	10.07 %	7.01 %
Y / Y Cost of Sales Growth	6.71 %	-4.67 %	2.89 %	6.81 %	5.1 %
Inventory Turnover Ratio (TTM)	3.22	3.23	3.45	3.62	3.65
SOLV's Total Ranking	# 1150	# 0	# 0	# 0	#
Average inventory processing period	113	113	106	101	100
Seq. Inventory Growth	-4.5 %	2.16 %	1.62 %	9.04 %	11.09 %
Seq. Cost of Sales Growth	15.95 %	-6.9 %	0.94 %	-2.08 %	3.59 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 50
Healthcare Sector	# 120
Overall Market	# 1150

Inventory Turnover Ratio Statistics
High	Average	Low
3.67	3.48	3.22
(Mar 31 2025)		(Jun 30 2026)

SOLV Company Profile >> Back to SOLV Efficiency Comparisons >> Compare SOLV Inventory Turnover Ratio to its Competitors

Financial Statements
Solventum's Inventories	$ 1,040 Millions	Visit SOLV's Balance sheet
Solventum's Cost of Revenues TTM	$ 3,421 Millions	Visit SOLV's Income Statement
What are SOLV's Sales?		Visit SOLV's Sales by Segment

Other Inventory Turnover Ratios
Solventum's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SOLV's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SOLV's Competitors
Inventory Turnover Ratio for SOLV's Suppliers
Inventory Turnover Ratio for SOLV's Customers

You may also want to know
SOLV's Sales Growth Rates	SOLV's Pe Price to earnings ratio	SOLV's Receivables Turnover Ratio	SOLV's Stock Quote
SOLV's Net Income Growth Rates	SOLV's Ps Price to Sales ratio	SOLV's Sales per Employee	SOLV's Asset Turnover Ratio
SOLV's Net Margin	SOLV's Pb Price to Book ratio	SOLV's Financial Strength Ratios	SOLV's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Polomar Health Services, Inc.	8.80	$ 1.233 Millions	$ 0 Millions
Myriad Genetics Inc	8.31	$ 250.700 Millions	$ 30 Millions
National Vision Holdings Inc	8.26	$ 841.416 Millions	$ 102 Millions
Autolus Therapeutics Plc	8.08	$ 99.009 Millions	$ 12 Millions
The Oncology Institute Inc	8.03	$ 160.655 Millions	$ 20 Millions
Nutriband Inc	7.92	$ 1.082 Millions	$ 0 Millions
Novavax inc	7.61	$ 88.541 Millions	$ 12 Millions
Inogen Inc	7.51	$ 196.617 Millions	$ 26 Millions
Moderna Inc	7.50	$ 1,707.000 Millions	$ 228 Millions
Cardiff Lexington Corporation	7.49	$ 4.042 Millions	$ 1 Millions
Pulse Biosciences Inc	7.45	$ 1.182 Millions	$ 0 Millions
Vanda Pharmaceuticals Inc	7.43	$ 13.506 Millions	$ 2 Millions
Carlsmed Inc	7.42	$ 13.955 Millions	$ 2 Millions
Adaptive Biotechnologies Corporation	7.26	$ 75.254 Millions	$ 10 Millions
Lifemd Inc	7.22	$ 22.284 Millions	$ 3 Millions
Brightspring Health Services Inc	6.35	$ 4,108.953 Millions	$ 647 Millions
Puma Biotechnology Inc	6.29	$ 58.199 Millions	$ 9 Millions
Adm Tronics Unlimited Inc	6.05	$ 1.970 Millions	$ 0 Millions
Sharps Technology Inc	5.68	$ 2.869 Millions	$ 1 Millions
Transmedics Group Inc	5.59	$ 276.120 Millions	$ 49 Millions
Cg Oncology Inc	5.47	$ 7.609 Millions	$ 1 Millions
Opko Health Inc	5.42	$ 348.206 Millions	$ 64 Millions
Charles River Laboratories International inc	5.39	$ 1,761.363 Millions	$ 327 Millions
Tactile Systems Technology Inc	5.12	$ 81.349 Millions	$ 16 Millions
Integer Holdings Corporation	5.03	$ 1,369.168 Millions	$ 272 Millions
Collegium Pharmaceutical Inc	4.99	$ 293.290 Millions	$ 59 Millions
Harrow Inc	4.93	$ 73.636 Millions	$ 15 Millions
Ufp Technologies Inc	4.93	$ 452.046 Millions	$ 92 Millions
Veracyte Inc	4.84	$ 102.741 Millions	$ 21 Millions
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions

Date modified: 2026-09-09T00:27:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.